2026 NPPES data Hematology (Internal Medicine) Physician NPI 1952740516 M.D., PH.D.
Verify on CMS →

CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.

Hematology (Internal Medicine) Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
194
Medicare Part D claims · 32 beneficiaries · Hematology (Internal Medicine) Physician avg: 693
Generic prescribing
47%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. is a Hematology (Internal Medicine) Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 194 claims across 32 beneficiaries — 53% brand-name prescribing .

What the federal data shows

CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. filed 194 Medicare Part D claims in 2023 as a Hematology (Internal Medicine) Physician in NEW YORK, New York, prescribing 47% generic.

194
Part D claims, 2023
47%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Board-eligible specialty (heuristic — not verified)

CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 06/17/2013

NPI 1952740516

Primary specialty

Hematology (Internal Medicine) Physician

Niche

1,436 US NPIs in this specialty

Medicare Part D claims

194 72% vs specialty avg

2023 prescription claims

Specialty avg: 693

Specialty distribution in New York

How Hematology (Internal Medicine) Physician compares to other specialties among New York providers

New York providers

Hematology (Internal Medicine) Physician share within New York

1. Hematology (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology (Internal Medicine) Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Hematology (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Hematology (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. is a Hematology (Internal Medicine) Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., PH.D.. NPI: 1952740516. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. appears in the CMS NPPES registry as a Hematology (Internal Medicine) Physician provider holding M.D., PH.D. credentials at 462 FIRST AVENUE, NEW YORK, NY, 10016, with a listed phone of (212) 562-1135. NPI 1952740516 was issued on 06/17/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PAPAZOGLU STATESCU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 194 prescription claims written by this provider, covering 32 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 53% brand-name and 47% generic by claim count, with an opioid prescribing rate of 8.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology (Internal Medicine) Physician is a narrow specialty nationwide, with 1,436 enrolled providers across 50 states and an average of 693 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

462 FIRST AVENUE
NEW YORK, NY 10016

Provider Details

NPI 1952740516
Specialty Hematology (Internal Medicine) Physician
Credentials M.D., PH.D.
Gender Male
NPI Issued 06/17/2013

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.. To verify CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. — brand share 53.0%
Specialty average (est.)

53% brand-name claims vs 47% generic, on 194 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

194
Total Claims
$1.1M
Total Drug Cost
32
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
240
Total Day Supply
6,744
Brand vs Generic
53% brand / 47% generic
Brand Drug Cost
$1.0M
Generic Drug Cost
$85K
Opioid Claims
17 (8.8% rate)

Patient Demographics

Average Patient Age
69.3 years
Avg HCC Risk Score
2.21

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Eliquis
Apixaban
38
Dexamethasone
14
Anastrozole
13
Ninlaro
Ixazomib Citrate
13
Tagrisso
Osimertinib Mesylate
12
Pomalyst
Pomalidomide
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology (Internal Medicine) Physician Overview

How CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. fits within the Hematology (Internal Medicine) Physician landscape nationally.

1,436
Hematology (Internal Medicine) Physician Providers in US
50
States with Hematology (Internal Medicine) Physician
693
Avg Claims per Provider

CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s 194 claims are below the specialty average of 693.

Nearby Hematology (Internal Medicine) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as PAPAZOGLU STATESCU.

Compare Hematology (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s specialty?
CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. specializes in Hematology (Internal Medicine) Physician and practices in NEW YORK, New York. Credentials: M.D., PH.D..
How much does CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. prescribe under Medicare Part D?
In 2023, CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. wrote 194 Medicare Part D claims totaling $1.1M in drug costs for 32 beneficiaries.
Where is CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. located?
CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. is located at 462 FIRST AVENUE, NEW YORK, NY, 10016. Phone: (212) 562-1135.
What is CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s NPI number?
CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s National Provider Identifier (NPI) is 1952740516, issued on 06/17/2013.
Does CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. prescribe more brand-name or generic drugs?
CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s prescribing is 53% brand-name and 47% generic drugs by claim count, with $1.0M in brand drug costs.
Does CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. prescribe opioids?
Yes, CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. had 17 opioid claims in 2023 with an opioid prescribing rate of 8.8%.
How many Hematology (Internal Medicine) Physician providers are there in the US?
There are 1,436 Hematology (Internal Medicine) Physician providers across 50 states in the US. The average Hematology (Internal Medicine) Physician provider writes 693 Medicare Part D claims per year.
What drugs does CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s most frequently prescribed drugs include Eliquis, Dexamethasone, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. accept Medicare?
CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D. appears in CMS Medicare data with 194 Part D claims and 32 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s credentials?
CRISTIAN PAPAZOGLU STATESCU, M.D., PH.D.'s NPI is 1952740516 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology